UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

Cardiovascular research, 2003-04, Vol.58 (1), p.32-45

2003

Volltextzugriff (PDF)

Left atrial appendage: structure, function, and role in thromboembolism

Heart, 1999-11, Vol.82 (5), p.547-554

1999

Volltextzugriff (PDF)

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

British heart journal, 2002-03, Vol.87 (3), p.220-228

2002

Volltextzugriff (PDF)

Early management of atrial fibrillation to prevent cardiovascular complications

European heart journal, 2014-06, Vol.35 (22), p.1448-1456

2014

Volltextzugriff (PDF)

Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease

Heart (British Cardiac Society), 1997-09, Vol.78 (3), p.273-277

1997

Volltextzugriff (PDF)

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion

Europace (London, England), 2014-05, Vol.16 (5), p.626-630

2014

Volltextzugriff (PDF)

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Europace (London, England), 2011-03, Vol.13 (3), p.308-328

2011

Volltextzugriff (PDF)

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs : Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Cardiovascular research, 2000-08, Vol.47 (2), p.219-233

2000

Volltextzugriff (PDF)

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

Circulation (New York, N.Y.), 1997-07, Vol.96 (2), p.404-407

1997

Volltextzugriff (PDF)

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Europace (London, England), 2011-05, Vol.13 (5), p.610-625

2011

Volltextzugriff (PDF)

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

European heart journal, 2015-09, Vol.36 (33), p.2239-2245

2015

Volltextzugriff (PDF)

Heart rate variability : Standards of measurement, physiological interpretation, and clinical use

European heart journal, 1996-03, Vol.17 (3), p.354-381

1996

Volltextzugriff (PDF)

Relation of Helicobacter pylori infection and coronary heart disease

British Heart Journal, 1994-05, Vol.71 (5), p.437-439

1994

Volltextzugriff (PDF)

Congenital and acquired long QT syndrome

European heart journal, 2000-08, Vol.21 (15), p.1232-1237

2000

Volltextzugriff (PDF)

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

European heart journal, 2000-08, Vol.21 (15), p.1216-1231

2000

Volltextzugriff (PDF)

The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography

Heart, 2009-10, Vol.95 (19), p.1561-1566

2009

Volltextzugriff (PDF)

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

Cardiovascular research, 2001-03, Vol.49 (4), p.741-750

2001

Volltextzugriff (PDF)

The Utilization of the Implantable Defibrillator—a European Enigma

European heart journal, 2000-12, Vol.21 (24), p.1998-2004

2000

Volltextzugriff (PDF)

Atrial fibrillation: current knowledge and recommendations for management

European heart journal, 1998-09, Vol.19 (9), p.1294-1320

1998

Volltextzugriff (PDF)

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

Europace (London, England), 2010-10, Vol.12 (10), p.1480-1489

2010

Volltextzugriff (PDF)

Atrioverter : An implantable device for the treatment of atrial fibrillation

Circulation (New York, N.Y.), 1998-10, Vol.98 (16), p.1651-1656

1998

Volltextzugriff (PDF)

The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarin

European heart journal, 2009-11, Vol.30 (21), p.2554-2555

Camm, A. John

2009

Volltextzugriff (PDF)

The changing circumstance of atrial fibrillation ‐ progress towards precision medicine

Journal of internal medicine, 2016-05, Vol.279 (5), p.412-427

2016

Volltextzugriff (PDF)

Increased monocyte tissue factor expression in coronary disease

British Heart Journal, 1995-01, Vol.73 (1), p.10-13

1995

Volltextzugriff (PDF)

Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction : results of a two-year follow-up study

Journal of the American College of Cardiology, 1996-02, Vol.27 (2), p.270-276

1996

Volltextzugriff (PDF)

1 – 25 von 919

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(900)
Mit Volltextzugriff
(875)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(587)
Life Sciences & Biomedicine
(580)
Humans
(560)
Cardiovascular System & Cardiology
(469)
Cardiac & Cardiovascular Systems
(460)
Biological And Medical Sciences
(283)
Male
(276)
Medical Sciences
(273)
Female
(271)
Middle Aged
(242)
Aged
(196)
Cardiology. Vascular System
(171)
Heart
(169)
Adult
(162)
Electrocardiography
(155)
Atrial Fibrillation
(130)
Cardiac Dysrhythmias
(105)
Risk Factors
(99)
Anti-Arrhythmia Agents - Therapeutic Use
(83)
Treatment Outcome
(70)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Heart Journal
(192)
Europace
(104)
Heart
(101)
Journal Of The American College Of Cardiology
(80)
British Heart Journal
(68)
Clinical Cardiology
(63)
Circulation
(62)
The New England Journal Of Medicine
(27)
Bmj
(19)
British Medical Journal
(19)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

Left atrial appendage: structure, function, and role in thromboembolism

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

Early management of atrial fibrillation to prevent cardiovascular complications

Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs : Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

Heart rate variability : Standards of measurement, physiological interpretation, and clinical use

Relation of Helicobacter pylori infection and coronary heart disease

Congenital and acquired long QT syndrome

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

The Utilization of the Implantable Defibrillator—a European Enigma

Atrial fibrillation: current knowledge and recommendations for management

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

Atrioverter : An implantable device for the treatment of atrial fibrillation

The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarin

The changing circumstance of atrial fibrillation ‐ progress towards precision medicine

Increased monocyte tissue factor expression in coronary disease

Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction : results of a two-year follow-up study

Aktive Filter

Suchergebnisse filtern